Barrett & Company’s Regional Health Properties, Inc. RHE Stock Holding History

Barrett & Company’s Portfolio RHE Stock Details RHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-209	Closed	-$752	–	643
2023 Q2	$752	Hold	209	–	–	﹤0.01%	571
2023 Q1	$713	Hold	209	–	–	﹤0.01%	557
2022 Q4	$694	Hold	209	–	–	﹤0.01%	561
2022 Q3	$694	Buy	+209	New	+$727	﹤0.01%	561

Other funds holding RHE

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barrett & Company's RHE Position: Q3 2023 in Review

Barrett & Company sold out of Regional Health Properties, Inc. (RHE) in Q3 2023, closing a stake of 209 shares — an estimated $752 sold.

Barrett & Company first reported a position in RHE in Q3 2022 and held it in 4 quarters. The position peaked at $752 in Q2 2023. 10 funds tracked by Wall St. Rank hold RHE as of Q3 2023.

Barrett & Company reported no remaining Regional Health Properties, Inc. position as of Q3 2023 after selling out during the quarter.
Barrett & Company sold 209 Regional Health Properties, Inc. shares in Q3 2023, an estimated $752.
Barrett & Company first reported a position in Regional Health Properties, Inc. in Q3 2022 and held it in 4 quarters.
Barrett & Company's Regional Health Properties, Inc. position peaked at $752 in Q2 2023.
10 funds tracked by Wall St. Rank held Regional Health Properties, Inc. as of Q3 2023.

Based on Barrett & Company's 13F filing for Q3 2023, filed 23 Oct 2023.